Wormser, Steere and Molins from the CDC are looking to promote antibody tests for Lyme disease while everyone knows these tests are virtually useless for 4-6 weeks after a tick bite and too restrictive thereafter. These two con artists need to retire.
--------- Original Message ----------
From: CARL TUTTLE <runagain@comcast.net>
To: tickbornedisease@hhs.gov, brett.giroir@hhs.gov
Cc: (79 Undisclosed recipients)
Date: February 18, 2019 at 11:11 AM
Subject: Diagnostic Tests for Lyme Disease
To: the Tick Borne Disease Working Group and ADM Brett P. Giroir, M.D., Assistant Secretary for Health,
Per the link below, Dr. Allen Steere filed a patent in 2013 for yet more antibody detection tests for Lyme disease: (Application #20150219646)
Compositions and Methods for the Detection of Bacterial Infections Associated with Lyme Disease
https://patents.justia.com/patent/20150219646
Faulty/misleading antibody tests are the root cause of unimaginable pain and suffering as we are all aware of Dr. Neil Spector’s need for a heart transplant after his antibody tests for Lyme were repeatedly negative. Lives are being ruined through false negative Lyme disease tests results.
Serology cannot be used to gauge treatment failure or success which is ideal for concealing chronic infection while perpetuating the dogma/racketeering scheme downplaying the severity of Lyme.
The following letter was forwarded to the Editors of multiple journals to warn of any future papers promoting antibody detection of Borrelia infection. It is time to fast track direct detection methods for all species of Borrelia in all stages of disease. Lyme has become a public health disaster under the direction of the US Centers for Disease Control.
Letter to the Editors:
---------- Original Message ----------
From: CARL TUTTLE <runagain@comcast.net>
To:editor.cmo@clinicalmedicaljournals.com,clinmicrobiol@microbiologyinsights.com,in3011@poh.osaka-med.ac.jp,volker.kroemker@hs-hannover.de,udai.singh@uscmed.sc.edu,rschooley@ucsd.edu
Date: February 18, 2019 at 7:49 AM
Subject: Diagnostic Tests for Lyme Disease
JAMA
Clinical Infectious Diseases
Clinical Microbiology
To the Editors,
Before Wormser, Steere and Molins (from the CDC) publish any of their promotional papers in your Journal regarding tests for Borrelia infection I would like to point out the following paper recently acknowledging that current antibody tests are inadequate for the management of Lyme disease.
Direct Diagnostic Tests for Lyme Disease
Clinical Infectious Diseases, ciy614, https://doi.org/10.1093/cid/ciy614
Published: 11 October 2018 (Coauthored by Dr. Paul Mead of the CDC)
Excerpt:
“… serologic tests cannot distinguish active infection, past infection, or reinfection. Reliable direct-detection methods for active B. burgdorferi infection have been lacking in the past but are needed and appear achievable.”
_____________________________
Failure to include this reference in any manuscript involving serology for the detection of Borrelia would be misleading the reader and may tarnish the peer-review process at your journal.
Sincerely,
Carl Tuttle
Hudson, NH USA